Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Production of immune response mediators by HT-29 intestinal cell-lines in the presence of Bifidobacterium-treated infant microbiota.

Arboleya S, Bahrami B, Macfarlane S, Gueimonde M, Macfarlane GT, de los Reyes-Gavilán CG.

Benef Microbes. 2015;6(4):543-52. doi: 10.3920/BM2014.0111. Epub 2015 Apr 22.

PMID:
25691102
2.

Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study.

Macfarlane S, Cleary S, Bahrami B, Reynolds N, Macfarlane GT.

Aliment Pharmacol Ther. 2013 Oct;38(7):804-16. doi: 10.1111/apt.12453. Epub 2013 Aug 20.

3.

Microbial biofilms and gastrointestinal diseases.

von Rosenvinge EC, O'May GA, Macfarlane S, Macfarlane GT, Shirtliff ME.

Pathog Dis. 2013 Feb;67(1):25-38. doi: 10.1111/2049-632X.12020. Epub 2013 Jan 29. Review.

4.

Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality?

Blackett KL, Siddhi SS, Cleary S, Steed H, Miller MH, Macfarlane S, Macfarlane GT, Dillon JF.

Aliment Pharmacol Ther. 2013 Jun;37(11):1084-92. doi: 10.1111/apt.12317. Epub 2013 Apr 22.

5.

Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.

Newton DF, Macfarlane S, Macfarlane GT.

Antimicrob Agents Chemother. 2013 May;57(5):2016-25. doi: 10.1128/AAC.00079-13. Epub 2013 Feb 12.

6.

Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration.

Fite A, Macfarlane S, Furrie E, Bahrami B, Cummings JH, Steinke DT, Macfarlane GT.

J Clin Microbiol. 2013 Mar;51(3):849-56. doi: 10.1128/JCM.02574-12. Epub 2012 Dec 26.

7.

Bacteria, colonic fermentation, and gastrointestinal health.

Macfarlane GT, Macfarlane S.

J AOAC Int. 2012 Jan-Feb;95(1):50-60. Review.

PMID:
22468341
8.

Effect of a synbiotic on microbial community structure in a continuous culture model of the gastric microbiota in enteral nutrition patients.

Smith AR, Macfarlane GT, Reynolds N, O'May GA, Bahrami B, Macfarlane S.

FEMS Microbiol Ecol. 2012 Apr;80(1):135-45. doi: 10.1111/j.1574-6941.2011.01279.x. Epub 2012 Jan 9.

9.

Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota.

Steed H, Macfarlane GT, Blackett KL, Macfarlane S, Miller MH, Bahrami B, Dillon JF.

FEMS Immunol Med Microbiol. 2011 Dec;63(3):346-54. doi: 10.1111/j.1574-695X.2011.00857.x. Epub 2011 Sep 8.

10.

Recommendations for probiotic use-2011 update.

Floch MH, Walker WA, Madsen K, Sanders ME, Macfarlane GT, Flint HJ, Dieleman LA, Ringel Y, Guandalini S, Kelly CP, Brandt LJ.

J Clin Gastroenterol. 2011 Nov;45 Suppl:S168-71. doi: 10.1097/MCG.0b013e318230928b.

PMID:
21992958
11.

Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics.

Macfarlane GT, Macfarlane S.

J Clin Gastroenterol. 2011 Nov;45 Suppl:S120-7. doi: 10.1097/MCG.0b013e31822fecfe. Review.

PMID:
21992950
12.

Mucosal biofilm communities in the human intestinal tract.

Macfarlane S, Bahrami B, Macfarlane GT.

Adv Appl Microbiol. 2011;75:111-43. doi: 10.1016/B978-0-12-387046-9.00005-0. Review.

PMID:
21807247
13.

Adherence and cytokine induction in Caco-2 cells by bacterial populations from a three-stage continuous-culture model of the large intestine.

Bahrami B, Child MW, Macfarlane S, Macfarlane GT.

Appl Environ Microbiol. 2011 May;77(9):2934-42. doi: 10.1128/AEM.02244-10. Epub 2011 Mar 4.

14.

Microbiological and immunological effects of enteral feeding on the upper gastrointestinal tract.

Smith AR, Macfarlane S, Furrie E, Ahmed S, Bahrami B, Reynolds N, Macfarlane GT.

J Med Microbiol. 2011 Mar;60(Pt 3):359-65. doi: 10.1099/jmm.0.026401-0. Epub 2010 Nov 18.

PMID:
21088127
15.

Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines.

Bahrami B, Macfarlane S, Macfarlane GT.

J Appl Microbiol. 2011 Jan;110(1):353-63. doi: 10.1111/j.1365-2672.2010.04889.x. Epub 2010 Nov 10.

16.

Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease.

Steed H, Macfarlane GT, Blackett KL, Bahrami B, Reynolds N, Walsh SV, Cummings JH, Macfarlane S.

Aliment Pharmacol Ther. 2010 Oct;32(7):872-83. doi: 10.1111/j.1365-2036.2010.04417.x.

17.

The gut microbiota in inflammatory bowel disease.

Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S.

Curr Pharm Des. 2009;15(13):1528-36. Review.

PMID:
19442170
18.

Acquisition, evolution and maintenance of the normal gut microbiota.

Macfarlane GT, Macfarlane LE.

Dig Dis. 2009;27 Suppl 1:90-8. doi: 10.1159/000268127. Epub 2010 Mar 4.

PMID:
20203503
19.

Intestinal bacteria and inflammatory bowel disease.

Macfarlane S, Steed H, Macfarlane GT.

Crit Rev Clin Lab Sci. 2009;46(1):25-54. doi: 10.1080/10408360802485792 . Review.

PMID:
19107650
20.

Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Macfarlane GT, Cummings JH.

West J Med. 1999 Sep;171(3):187-91. No abstract available.

21.

Prebiotics, synbiotics and inflammatory bowel disease.

Steed H, Macfarlane GT, Macfarlane S.

Mol Nutr Food Res. 2008 Aug;52(8):898-905. doi: 10.1002/mnfr.200700139. Review.

PMID:
18383235
22.

Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics.

Macfarlane GT, Steed H, Macfarlane S.

J Appl Microbiol. 2008 Feb;104(2):305-44. doi: 10.1111/j.1365-2672.2007.03520.x. Review.

23.

Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples.

Ahmed S, Macfarlane GT, Fite A, McBain AJ, Gilbert P, Macfarlane S.

Appl Environ Microbiol. 2007 Nov;73(22):7435-42. Epub 2007 Sep 21.

24.

Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus.

Macfarlane S, Furrie E, Macfarlane GT, Dillon JF.

Clin Infect Dis. 2007 Jul 1;45(1):29-38. Epub 2007 May 22.

PMID:
17554697
25.

Lactobacillus gasseri Gasser AM63(T) degrades oxalate in a multistage continuous culture simulator of the human colonic microbiota.

Lewanika TR, Reid SJ, Abratt VR, Macfarlane GT, Macfarlane S.

FEMS Microbiol Ecol. 2007 Jul;61(1):110-20. Epub 2007 May 16.

26.

Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut.

Macfarlane GT, Macfarlane S.

Curr Opin Biotechnol. 2007 Apr;18(2):156-62. Epub 2007 Feb 2. Review.

PMID:
17276052
27.

Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut.

Macfarlane S, Macfarlane GT.

Appl Environ Microbiol. 2006 Sep;72(9):6204-11.

28.

Review article: prebiotics in the gastrointestinal tract.

Macfarlane S, Macfarlane GT, Cummings JH.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):701-14. Review.

29.

Dissimilatory amino Acid metabolism in human colonic bacteria.

Smith EA, Macfarlane GT.

Anaerobe. 1997 Oct;3(5):327-37.

PMID:
16887608
30.

Studies on the effect of system retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques.

Child MW, Kennedy A, Walker AW, Bahrami B, Macfarlane S, Macfarlane GT.

FEMS Microbiol Ecol. 2006 Feb;55(2):299-310.

31.

Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses.

Hopkins MJ, Macfarlane GT, Furrie E, Fite A, Macfarlane S.

FEMS Microbiol Ecol. 2005 Sep 1;54(1):77-85.

32.
33.

Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients.

O'May GA, Reynolds N, Macfarlane GT.

Appl Environ Microbiol. 2005 Aug;71(8):4777-83.

34.

Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria.

Furrie E, Macfarlane S, Thomson G, Macfarlane GT; Microbiology & Gut Biology Group; Tayside Tissue & Tumour Bank.

Immunology. 2005 Aug;115(4):565-74.

35.
36.

Mucosal bacteria in ulcerative colitis.

Macfarlane S, Furrie E, Kennedy A, Cummings JH, Macfarlane GT.

Br J Nutr. 2005 Apr;93 Suppl 1:S67-72.

PMID:
15877898
37.

Bacterial milieu and mucosal bacteria in ulcerative colitis.

Macfarlane GT, Furrie E, Macfarlane S.

Novartis Found Symp. 2004;263:57-64; discussion 64-70, 211-8. Review.

PMID:
15669634
38.
40.
41.

Bacterial diversity in the human gut.

Macfarlane S, Macfarlane GT.

Adv Appl Microbiol. 2004;54:261-89. Review. No abstract available.

PMID:
15251284
42.

Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis.

Macfarlane S, Furrie E, Cummings JH, Macfarlane GT.

Clin Infect Dis. 2004 Jun 15;38(12):1690-9. Epub 2004 May 25.

PMID:
15227614
44.

Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction.

Fite A, Macfarlane GT, Cummings JH, Hopkins MJ, Kong SC, Furrie E, Macfarlane S.

Gut. 2004 Apr;53(4):523-9.

45.
46.

Degradation of cross-linked and non-cross-linked arabinoxylans by the intestinal microbiota in children.

Hopkins MJ, Englyst HN, Macfarlane S, Furrie E, Macfarlane GT, McBain AJ.

Appl Environ Microbiol. 2003 Nov;69(11):6354-60.

47.

Regulation of short-chain fatty acid production.

Macfarlane S, Macfarlane GT.

Proc Nutr Soc. 2003 Feb;62(1):67-72. Review.

PMID:
12740060
48.

Intestinal bacteria and ulcerative colitis.

Cummings JH, Macfarlane GT, Macfarlane S.

Curr Issues Intest Microbiol. 2003 Mar;4(1):9-20. Review.

PMID:
12691258
49.

Probiotics, infection and immunity.

Macfarlane GT, Cummings JH.

Curr Opin Infect Dis. 2002 Oct;15(5):501-6. Review.

PMID:
12686883
50.

Supplemental Content

Loading ...
Support Center